Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Recent Registrations
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
January -
February
-
March
-
April
-
May
-
June
-
July
-
August
-
September
-
Oktober
-
November
-
December
|
2002
-
2003
-
2004
-
2005
-
2006
-
2007
-
2008
-
2009
-
2010
-
2011
- 2012 -
2013
-
2014
-
2015
-
2016
-
2017
-
2018
-
2019
-
2020
-
2021
-
2022
-
2023
-
2024
-
2025
January 2012 - 46 products
IP
CI
Viramune
30 Tablet(s)
180.75
211.90
20 %
Delayed release tablets: Nevirapinum 400 mg
Boehringer Ingelheim
(Schweiz) GmbH
A / SL / SO
FB
G
IP
CI
Pemzek 4 mg
7 Tablet(s)
1.64
11.00
10 %
Tablets: Candesartanum Cilexetilum 4 mg
AstraZeneca AG
B / SL / SO
FB
G
IP
CI
Pemzek 8 mg
28 Tablet(s)
8.21
18.10
10 %
Tablets: Candesartanum Cilexetilum 8 mg
AstraZeneca AG
B / SL / SO
FB
G
IP
CI
Pemzek 8 mg
98 Tablet(s)
24.30
42.70
10 %
Tablets: Candesartanum Cilexetilum 8 mg
AstraZeneca AG
B / SL / SO
FB
G
IP
CI
Pemzek 16 mg
28 Tablet(s)
10.05
27.25
10 %
Tablets: Candesartanum Cilexetilum 16 mg
AstraZeneca AG
B / SL / SO
FB
G
IP
CI
Pemzek 16 mg
98 Tablet(s)
31.54
50.55
10 %
Tablets: Candesartanum Cilexetilum 16 mg
AstraZeneca AG
B / SL / SO
FB
G
IP
CI
Pemzek 32 mg
28 Tablet(s)
15.59
33.20
10 %
Tablets: Candesartanum Cilexetilum 32 mg
AstraZeneca AG
B / SL / SO
FB
G
IP
CI
Pemzek 32 mg
98 Tablet(s)
44.77
64.90
10 %
Tablets: Candesartanum Cilexetilum 32 mg
AstraZeneca AG
B / SL / SO
FB
G
IP
CI
Pemzek PLUS 8/12.5 mg
28 Tablet(s)
8.29
18.20
10 %
Tablets: 2 Active Agents
AstraZeneca AG
B / SL / SO
FB
G
IP
CI
Pemzek PLUS 8/12.5 mg
98 Tablet(s)
27.09
45.75
10 %
Tablets: 2 Active Agents
AstraZeneca AG
B / SL / SO
FB
G
IP
CI
Pemzek PLUS 16/12.5 mg
28 Tablet(s)
10.26
27.55
10 %
Tablets: 2 Active Agents
AstraZeneca AG
B / SL / SO
FB
G
IP
CI
Pemzek PLUS 16/12.5 mg
98 Tablet(s)
35.85
55.20
10 %
Tablets: 2 Active Agents
AstraZeneca AG
B / SL / SO
FB
G
IP
CI
Pemzek PLUS 32/12.5 mg
28 Tablet(s)
14.94
32.40
10 %
Tablets: 2 Active Agents
AstraZeneca AG
B / SL / SO
FB
G
IP
CI
Pemzek PLUS 32/12.5 mg
98 Tablet(s)
37.38
56.90
10 %
Tablets: 2 Active Agents
AstraZeneca AG
B / SL / SO
FB
G
IP
CI
Pemzek PLUS 32/25 mg
28 Tablet(s)
14.94
32.40
10 %
Tablets: 2 Active Agents
AstraZeneca AG
B / SL / SO
FB
G
IP
CI
Pemzek PLUS 32/25 mg
98 Tablet(s)
37.38
56.90
10 %
Tablets: 2 Active Agents
AstraZeneca AG
B / SL / SO
FB
G
IP
CI
Cetirizin Spirig HC
10 Tablet(s)
4.15
7.65
10 %
Coated tablets: Cetirizini Dihydrochloridum 10 mg
Spirig HealthCare AG
D / SL / SG
FB
G
IP
CI
Cetirizin Spirig HC
30
10.60
19.55
10 %
Coated tablets: Cetirizini Dihydrochloridum 10 mg
Spirig HealthCare AG
D / SL / SG
FB
G
IP
CI
Cetirizin Spirig HC
50
14.80
27.30
10 %
Coated tablets: Cetirizini Dihydrochloridum 10 mg
Spirig HealthCare AG
D / SL / SG
FB
G
IP
CI
Candesartan HCT Zentiva
8/12.5mg
30
8.23
18.15
10 %
Tablets: 2 Active Agents
Helvepharm AG
B / SL / SG
FB
G
IP
CI
Candesartan HCT Zentiva
8/12.5mg
100
25.59
44.20
10 %
Tablets: 2 Active Agents
Helvepharm AG
B / SL / SG
FB
G
IP
CI
Candesartan HCT Zentiva
16/12.5mg
30
10.19
27.45
10 %
Tablets: 2 Active Agents
Helvepharm AG
B / SL / SG
FB
G
IP
CI
Candesartan HCT Zentiva
16/12.5mg
100
33.87
53.20
10 %
Tablets: 2 Active Agents
Helvepharm AG
B / SL / SG
FB
G
IP
CI
Candesartan HCT Zentiva
32/12.5mg
28
11.01
28.35
10 %
Tablets: 2 Active Agents
Helvepharm AG
B / SL / SG
FB
G
IP
CI
Candesartan HCT Zentiva
32/12.5mg
98
37.38
56.90
10 %
Tablets: 2 Active Agents
Helvepharm AG
B / SL / SG
FB
G
IP
CI
Candesartan HCT Zentiva
32/25 mg
28
11.01
28.35
10 %
Tablets: 2 Active Agents
Helvepharm AG
B / SL / SG
FB
G
IP
CI
Candesartan HCT Zentiva
32/25 mg
98
37.38
56.90
10 %
Tablets: 2 Active Agents
Helvepharm AG
B / SL / SG
FB
G
L
IP
CI
CM
Pravastatin Spirig HC
10mg
30 Tablet(s)
4.56
14.20
10 %
Tablets: Pravastatinum Natricum 10 mg
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
CI
CM
Pravastatin Spirig HC
10mg
100 Tablet(s)
14.00
31.65
10 %
Tablets: Pravastatinum Natricum 10 mg
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
CI
CM
Pravastatin Spirig HC
20mg
30 Tablet(s)
5.80
15.55
10 %
Tablets: Pravastatinum Natricum 20 mg
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
CI
CM
Pravastatin Spirig HC
20mg
100 Tablet(s)
27.06
45.80
10 %
Tablets: Pravastatinum Natricum 20 mg
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
CI
CM
Pravastatin Spirig HC
40mg
30 Tablet(s)
9.85
27.15
10 %
Tablets: Pravastatinum Natricum 40 mg
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
CI
CM
Pravastatin Spirig HC
40mg
100 Tablet(s)
43.08
63.30
10 %
Tablets: Pravastatinum Natricum 40 mg
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
Numeta Ped G16% E
6 x 500 ml
591.00
659.15
10 %
Infusionslösung zur totalen parenteralen Ernährung: 25 Active Agents
Infusionslösung zur totalen parenteralen Ernährung: 2 Active Agents
Infusionslösung zur totalen parenteralen Ernährung: 2 Active Agents
Baxter AG
B / SL
FB
G
L
IP
CI
Movicol Liquid Orange
500 ml
7.66
17.55
10 %
Konzentrat zur Herstellung einer Lösung zum Einnehmen: 4 Active Agents
Norgine AG
B / SL
FB
G
IP
CI
Tyarena
‐
I
21 Tablet(s)
PR
PR
k.A.
Coated tablets: 2 Active Agents
Mepha Pharma AG
B / LPPV
FB
G
IP
CI
Tyarena
3 x 21 Tablet(s)
PR
PR
k.A.
Coated tablets: 2 Active Agents
Mepha Pharma AG
B / LPPV
FB
G
IP
CI
Tyarena
6 x 21 Tablet(s)
PR
PR
k.A.
Coated tablets: 2 Active Agents
Mepha Pharma AG
B / LPPV
FB
G
IP
CI
Pemzek 4 mg
28
PR
PR
k.A.
Tablets: Candesartanum Cilexetilum 4 mg
AstraZeneca AG
B
FB
G
IP
CI
Pemzek 4 mg
30
PR
PR
k.A.
Tablets: Candesartanum Cilexetilum 4 mg
AstraZeneca AG
B
FB
G
IP
CI
Pemzek 8 mg
30
PR
PR
k.A.
Tablets: Candesartanum Cilexetilum 8 mg
AstraZeneca AG
B
FB
G
IP
CI
Pemzek 16 mg
30
PR
PR
k.A.
Tablets: Candesartanum Cilexetilum 16 mg
AstraZeneca AG
B
FB
G
IP
CI
Pemzek 32 mg
30
PR
PR
k.A.
Tablets: Candesartanum Cilexetilum 32 mg
AstraZeneca AG
B
FB
G
IP
CI
Pemzek PLUS 8/12.5 mg
30
PR
PR
k.A.
Tablets: 2 Active Agents
AstraZeneca AG
B
FB
G
IP
CI
Pemzek PLUS 16/12.5 mg
30
PR
PR
k.A.
Tablets: 2 Active Agents
AstraZeneca AG
B
FB
G
IP
Numeta Ped G19% E
6 x 1000 ml
PR
PR
k.A.
Infusionslösung zur totalen parenteralen Ernährung: 25 Active Agents
Infusionslösung zur totalen parenteralen Ernährung: 2 Active Agents
Infusionslösung zur totalen parenteralen Ernährung: 2 Active Agents
Baxter AG
B
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home